{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:23:36Z","timestamp":1777991016918,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21590986"],"award-info":[{"award-number":["21590986"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.02.026","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T17:01:53Z","timestamp":1329930113000},"page":"2633-2639","source":"Crossref","is-referenced-by-count":27,"title":["Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine"],"prefix":"10.1016","volume":"30","author":[{"given":"Masato","family":"Kono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Uchijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Giermasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Kalinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingo","family":"Chida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.02.026_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","article-title":"T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal","volume":"20","author":"Kalinski","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/79734","article-title":"Dendritic cell regulation of Th1-Th2 development","volume":"1","author":"Moser","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0020","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.162.6.3231","article-title":"Final maturation of dendritic cells is associated with impaired responsiveness to IFN-\u03b3 and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells","volume":"162","author":"Kalinski","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/79758","article-title":"Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells","volume":"1","author":"Langenkamp","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2010.03.002","article-title":"Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors","volume":"22","author":"Kalinski","year":"2010","journal-title":"Seminer Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0035","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-04-1261","article-title":"\u03b1-type-1 polarized dendritic cells: a novel immuinization tool with optimized CTL-inducing activity","volume":"64","author":"Mailliard","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0040","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1016\/j.vaccine.2007.07.031","article-title":"The clinical grade maturation cocktail monophosphoryl lipid A plus IFN\u03b3 generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization","volume":"25","author":"ten Brinke","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0045","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.164.9.4507","article-title":"Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction","volume":"164","author":"Vieira","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4049\/jimmunol.0902062","article-title":"Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells","volume":"184","author":"Watchmaker","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/IR:36:1:137","article-title":"Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccine","volume":"36","author":"Kalinski","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20011662","article-title":"Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses","volume":"195","author":"Mailliard","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0065","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.171.5.2366","article-title":"Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function","volume":"171","author":"Mailliard","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0070","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00262-008-0648-5","article-title":"Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines","volume":"58","author":"Giermasz","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1574-695X.2007.00316.x","article-title":"Immunization with dendritic cells loaded with \u03b1-galactosylceramide at priming phase, but not at boosting phase, enhances cytotoxic T lymphocyte activity against infection by intracellular bacteria","volume":"51","author":"Enomoto","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0080","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1016\/j.vaccine.2008.03.101","article-title":"Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung","volume":"26","author":"Hashimoto","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00262-011-1015-5","article-title":"Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells","volume":"60","author":"Kato","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0090","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1128\/IAI.71.4.1748-1754.2003","article-title":"Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene","volume":"71","author":"Nakamura","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0095","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.vaccine.2005.11.026","article-title":"Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A","volume":"24","author":"Nakano","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2008-0446OC","article-title":"Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen","volume":"41","author":"Ozawa","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.192.6.823","article-title":"Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells","volume":"192","author":"Hochrein","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0110","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.165.4.1877","article-title":"IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells","volume":"165","author":"Kalinski","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0120","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.169.9.4936","article-title":"Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells","volume":"169","author":"Hamilton","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8+-and CD4+-T-cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/0008-5472.CAN-08-2915","article-title":"Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells-significant roles of CXCL10","volume":"69","author":"Fujita","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0140","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1158\/0008-5472.CAN-05-1692","article-title":"Tumor cell loaded type-1 polarized dendritic cells induce Th-1 mediated tumor immunity","volume":"65","author":"Hokey","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.cji.0000211316.15278.6e","article-title":"Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro","volume":"30","author":"Wesa","year":"2007","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1189\/jlb.1107737","article-title":"Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia","volume":"84","author":"Lee","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2010.30.7744","volume":"29","author":"Okada","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2006.07.001","article-title":"Inflaming the CD8+ T cell response","volume":"25","author":"Haring","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0170","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/764542","article-title":"Induction of specific CD8+ T cells against intracellular bacteria by CD8+ T-cell-oriented immunization approaches","author":"Nagata","year":"2010","journal-title":"J Biomed Biothechnol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0175","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/IAI.72.4.2014-2021.2004","article-title":"Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB\/MPT51","volume":"72","author":"Miki","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0180","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1128\/IAI.72.7.3829-3837.2004","article-title":"Identification of murine H2-Dd- and H2-Ab -restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis","volume":"72","author":"Suzuki","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0185","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.172.5.2818","article-title":"IL-12 priming during in vitro antigenic stimulation changes properties of CD8T cells and increases generation of effector and memory cells","volume":"172","author":"Chang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0190","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.4049\/jimmunol.181.12.8576","article-title":"IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17","volume":"181","author":"Henry","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2010.04.007","article-title":"The roles IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: insights from a DC vaccination model","volume":"264","author":"Henry","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0200","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/intimm\/dxm072","article-title":"Phenotypic changes induced by IL-12 priming regulate effector and memory CD8T cell differentiation","volume":"19","author":"Lee","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0205","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.4049\/jimmunol.0803484","article-title":"Programming for CD8 T cell memory development requires IL-12 or type I IFN","volume":"182","author":"Xiao","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/cmi.2008.18","article-title":"Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion","volume":"5","author":"Ye","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0215","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.20070176","article-title":"A subset of dendritic cells induces CD4+ T cells to produce IFN-\u03b3 by an IL-12-independent but CD70-dependent mechanism in vivo","volume":"204","author":"Soares","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0220","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20062305","article-title":"CD8\u2212 DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS","volume":"204","author":"Skokos","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0225","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.4049\/jimmunol.0901477","article-title":"Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1T cells in vitro","volume":"183","author":"Lipscomb","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0230","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.gt.3302941","article-title":"Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity","volume":"14","author":"Tatsumi","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0235","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1158\/0008-5472.CAN-07-6494","article-title":"Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine","volume":"68","author":"Gustafsson","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2012.02.026_bib0240","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-3083.2011.02580.x","article-title":"Tumour-loaded \u03b1-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile","volume":"74","author":"Gustafsson","year":"2011","journal-title":"Scand J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T15:27:16Z","timestamp":1687274836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12002095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}